Safety, Effectiveness and Immunogenicity of heterologous mRNA-1273 Boost
South Africa
Get Microdata
Reference ID
SafetyEffectivenessandImmunogenicityofheterologousmRNA-1273Boost
Producer(s)
Nigel Garrett, Tarylee Reddy, Nonhlanhla Yende-Zuma, Azwidhwi Takalani, Kubashni Woeber, Annie Bodenstein, Phumeza Jonas, Imke Engelbrecht, Waasila Jassat, Harry Moultrie, Debbie Bradshaw, Ishen Seocharan, Jackline Odhiambo, Kentse Khuto, Simone I. Richardson, Millicent A. Omondi, Rofhiwa Nesamari,
Metadata
Created on
Apr 29, 2024
Last modified
Apr 29, 2024
Page views
25369
Downloads
2
- Data files
- SHERPA_Safetydata
resp_specify (resp_specify)
Data file: SHERPA_Safetydata
Overview
Valid:
20
Invalid:
0
Type:
Discrete
Width:
91
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| Bilateral crepitations | 1 |
5%
|
|
| Bilateral wheezing mild -ANCS | 1 |
5%
|
|
| COPD creps bilaterally | 1 |
5%
|
|
| Equal but globally quiet, decreased air entry | 1 |
5%
|
|
| Known asthmatic with scattered wheezes bilaterally | 1 |
5%
|
|
| LEFT Sided upper zone creps NCS for study | 1 |
5%
|
|
| Left upper lobe+ right lower lobe mild respiratory wheeze most likely from MDR TB scarrring | 1 |
5%
|
|
| Mild COPD - ncs | 1 |
5%
|
|
| Mild wheeze left upper lobe. Known smoker. NCS | 1 |
5%
|
|
| Mild wheezes bilaterally | 1 |
5%
|
|
| Normal | 1 |
5%
|
|
| Previous left lobectomy - ncs | 1 |
5%
|
|
| Prolonged slow expiration | 1 |
5%
|
|
| RT middle zone anterior decreased air entry | 1 |
5%
|
|
| Scarring Previous TB - NCS | 1 |
5%
|
|
| Scattered wheezes patient known with asthma. | 1 |
5%
|
|
| bilateral wheezes | 1 |
5%
|
|
| bilateral wheezes, inspiratory and expiratory | 1 |
5%
|
|
| expiratory wheezes | 1 |
5%
|
|
| expiratory wheezes, known asthmatic | 1 |
5%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.